Clinical trial
Nimodipine for Treating Acute Massive Cerebral Infarction: a Randomized, Double-blind, Controlled Clinical Study
NCT02248233 is registered in ClinicalTrials.gov with Fengtian Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Nimodipine for Treating Acute Massive Cerebral Infarction: a Randomized, Double-blind, Controlled Clinical Study
- Lead sponsor
- Fengtian Hospital
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- October 31, 2014
- Completion date
- September 30, 2015
- Enrollment
- 72 (actual)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.